Facible Awarded National Institutes of Health Grant to Advance Rapid Test for SARS-CoV-2 - Read the Press Release

Newsfeed

Press Releases

DECEMBER 15, 2020

Facible Awarded National Institutes of Health Grant to Advance Rapid Test for SARS-CoV-2 (COVID-19)

Facible Biodiagnostics, a purpose-driven startup company focused on creating fast, accurate and affordable hospital-grade biodiagnostic tests, today announced a $250,000 award from The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech initiative.

For press inquires, please contact:

Phone icon

1-208-567-8910

Envelope icon

Katie Dodge, JPA Health - kdodge@jpa.com